OIS INDEX
The OIS Index Consists of Publicly Traded Growth Companies in Ophthalmology
Powered By:
We introduced the OIS Index, a composite of ophthalmic growth stocks, in October 2016 at OIS@AAO with the purpose of tracking the performance of our sector. The components of the OIS Index are publicly traded growth companies in ophthalmology that derive at least half of their value from ophthalmic products and technology. The index was launched with a base value of 1,000. The index is weighted about 50% biopharma and 50% ophthalmic device, based on company valuations. Company market caps range from $30 million to $30 billion, with a median of $200 million.
OIS Index
September 1, 2020
1,027.77
| Index Performance (% Chg.) | 1 Month | 3 Months | 1 Year |
|---|---|---|---|
| OIS Index (OIS) | -0.4% | -5.0% | -1.8% |
| NASDAQ Biotechnology Index (NBI) | 0.9% | 0.8% | 31.8% |
| US Medical Device Index (IHI) | 3.7% | 13.2% | 21.9% |
| US Market: Russell 3000 Index (R3000) | 7.1% | 15.5% | 19.2% |
OIS Index - Three Month Performance
May 29, 2020 - August 31, 2020
Index values are scaled to 100 as of the initial date in the chart.
OIS Index - One Year Performance
August 30, 2019 - August 31, 2020
Index values are scaled to 100 as of the initial date in the chart.